Predictors of latent tuberculosis infection treatment completion in the United States: an inner city experience

Por Hirsch-Moverman, Y., Bethel, J., Colson, P. W., Franks, J., El-Sadr, W.
Publicado no Int J Tuberc Lung Dis (2010)

Can a peer-based intervention impact adherence to the treatment of latent tuberculous infection?

Por Hirsch-Moverman, Y., Colson, P. W., Bethel, J., Franks, J., El-Sadr, W. M.
Publicado no Int J Tuberc Lung Dis (2013)

Depressive symptoms and hazardous/harmful alcohol use are prevalent and correlate with stigma among TB-HIV patients in Lesotho

Por Hayes-Larson, E., Hirsch-Moverman, Y., Saito, S., Frederix, K., Pitt, B., Maama-Maime, L., Howard, A. A.
Publicado no Int J Tuberc Lung Dis (2017)

Latent tuberculous infection in the United States and Canada: who completes treatment and why?

Por Hirsch-Moverman, Y., Shrestha-Kuwahara, R., Bethel, J., Blumberg, H. M., Venkatappa, T. K., Horsburgh, C. R., Colson, P. W.
Publicado no Int J Tuberc Lung Dis (2015)

Characteristics and costs of multidrug-resistant tuberculosis in-patient care in the United States, 2005–2007

Por Marks, S. M., Hirsch-Moverman, Y., Salcedo, K., Graviss, E. A., Oh, P., Seaworth, B., Flood, J., Armstrong, L., Armitige, L., Mase, S.
Publicado no Int J Tuberc Lung Dis (2016)

Risk factors for transmission of tuberculosis among United States-born African Americans and Whites

Por Pagaoa, M. A., Royce, R. A., Chen, M. P., Golub, J. E., Davidow, A. L., Hirsch-Moverman, Y., Marks, S. M., Teeter, L. D., Thickstun, P. M., Katz, D. J.
Publicado no Int J Tuberc Lung Dis (2015)

Re-inventing adherence: toward a patient-centered model of care for drug-resistant tuberculosis and HIV

Por O’Donnell, M. R., Daftary, A., Frick, M., Hirsch-Moverman, Y., Amico, K. R., Senthilingam, M., Wolf, A., Metcalfe, J. Z., Isaakidis, P., Davis, J. L., Zelnick, J. R., Brust, J. C. M., Naidu, N., Garretson, M., Bangsberg, D. R., Padayatchi, N., Friedland, G.
Publicado no Int J Tuberc Lung Dis (2016)